256 related articles for article (PubMed ID: 17063150)
1. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
Stein MA; Waldman ID; Sarampote CS; Seymour KE; Robb AS; Conlon C; Kim SJ; Cook EH
Neuropsychopharmacology; 2005 Jul; 30(7):1374-82. PubMed ID: 15827573
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
[TBL] [Abstract][Full Text] [Related]
4. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
5. Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD.
Giana G; Romano E; Porfirio MC; D'Ambrosio R; Giovinazzo S; Troianiello M; Barlocci E; Travaglini D; Granstrem O; Pascale E; Tarani L; Curatolo P; Laviola G; Adriani W
J Neuroimmunol; 2015 Jan; 278():212-22. PubMed ID: 25468771
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
Kambeitz J; Romanos M; Ettinger U
Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?
Hong SB; Kim JW; Cho SC; Shin MS; Kim BN; Yoo HJ
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):343-52. PubMed ID: 23083021
[TBL] [Abstract][Full Text] [Related]
8. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.
Hamarman S; Fossella J; Ulger C; Brimacombe M; Dermody J
J Child Adolesc Psychopharmacol; 2004; 14(4):564-74. PubMed ID: 15662148
[TBL] [Abstract][Full Text] [Related]
11. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children.
Cheon KA; Kim BN; Cho SC
Neuropsychopharmacology; 2007 Jun; 32(6):1377-83. PubMed ID: 17077808
[TBL] [Abstract][Full Text] [Related]
12. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
[TBL] [Abstract][Full Text] [Related]
13. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.
Contini V; Victor MM; Marques FZ; Bertuzzi GP; Salgado CA; Silva KL; Sousa NO; Grevet EH; Belmonte-de-Abreu P; Bau CH
J Neural Transm (Vienna); 2010 Feb; 117(2):269-76. PubMed ID: 20049490
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter genotype influences the physiological response to medication in ADHD.
Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
[TBL] [Abstract][Full Text] [Related]
15. The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD.
Thakur GA; Grizenko N; Sengupta SM; Schmitz N; Joober R
BMC Psychiatry; 2010 Jun; 10():50. PubMed ID: 20569447
[TBL] [Abstract][Full Text] [Related]
16. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
[TBL] [Abstract][Full Text] [Related]
17. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
18. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
McGough JJ; McCracken JT; Loo SK; Manganiello M; Leung MC; Tietjens JR; Trinh T; Baweja S; Suddath R; Smalley SL; Hellemann G; Sugar CA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
Gruber R; Joober R; Grizenko N; Leventhal BL; Cook EH; Stein MA
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):233-9. PubMed ID: 19519258
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
